Protein engineering for improved pharmacologic characteristics of established monoclonal antibody-based therapeutics

Clin Pharmacokinet. 2014 Oct;53(10):863-4. doi: 10.1007/s40262-014-0186-6.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / genetics*
  • Antibodies, Monoclonal / pharmacokinetics
  • Antibodies, Monoclonal / pharmacology*
  • Humans
  • Protein Engineering*

Substances

  • Antibodies, Monoclonal